Pregnancy Termination in Patients With Rheumatic Diseases

被引：1

作者：

Mo, Sophy ^{[1
]}

Malhame, Isabelle ^{[2
]}

Schneiderman, Megan ^{[1
,3
]}

Vinet, Evelyne ^{[2
]}

机构：

[1] McGill Univ, Montreal, PQ, Canada

[2] McGill Univ, McGill Univ Hlth Ctr, Ctr Outcomes Res & Evaluat, Res Inst McGill Univ Hlth Ctr RI MUHC, Montreal, PQ, Canada

[3] St Marys Hosp, Montreal, PQ, Canada

来源：

ARTHRITIS CARE & RESEARCH | 2022年 / 74卷 / 10期

关键词：

ANTIPHOSPHOLIPID SYNDROME; PULMONARY-HYPERTENSION; INDUCED ABORTIONS; MEDICAL ABORTION; WOMEN; MANAGEMENT; OUTCOMES; METHOTREXATE; ARTHRITIS; RISK;

D O I：

10.1002/acr.24835

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Rheumatic diseases affect women during their reproductive years. Many women with rheumatic diseases become pregnant; some undergo pregnancy termination. However, there are no official guidelines on pregnancy termination in patients with rheumatic diseases. This work provides an overview of factors that health care professionals must consider. We highlight areas that require further studies and the importance of pregnancy planning and contraception counseling. Patients with rheumatic diseases need to be informed of adverse maternal and fetal outcomes of pregnancy to make informed reproductive decisions and reduce the need for pregnancy terminations.

引用

页码：1745 / 1750

页数：6

共 45 条

[1] Renal co-morbidity in patients with rheumatic diseases [J].